CN109897843A - A kind of recombination echinocandin B deacylase mutant and application - Google Patents
A kind of recombination echinocandin B deacylase mutant and application Download PDFInfo
- Publication number
- CN109897843A CN109897843A CN201910155559.4A CN201910155559A CN109897843A CN 109897843 A CN109897843 A CN 109897843A CN 201910155559 A CN201910155559 A CN 201910155559A CN 109897843 A CN109897843 A CN 109897843A
- Authority
- CN
- China
- Prior art keywords
- auebda
- deacylase
- mutant
- echinocandin
- ala
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
It is to obtain the 287th, 527 progress single mutation of amino acid sequence shown in SEQ ID No.2 or double mutation the invention discloses a kind of recombination echinocandin B deacylase mutant and the application in biocatalysis echinocandin B synthesis echinocandin B parent nucleus, the deacylase mutant;The present invention changes the conformation of AuEBDA primary structure and enzyme, improves the catalytic performance of AuEBDA by mutation auebda gene order.Present system analyzes G287Q and R527V and replaces on the active influence of ECB deacylase.The enzyme activity for the double-mutant AuEBDA-G287Q/R527V that the present invention constructs improves 2.5 times compared with parent enzyme wild type AuEBDA enzyme activity, catalytic efficiency kcat/KmIncrease by 2.9 times.
Description
Technical field
The present invention relates to the actinoplanes utahensis deacylases of an energy efficient catalytic echinocandin B amido bond hydrolysis
AuEBDA and its encoding gene auebda.Half is carried out to AuEBDA by bioinformatics, homologous modeling and molecular docking method
The AuEBDA mutant enzyme for having robustness using Protocols in Molecular Biology, catalysis are realized in design and rational and molecular modification for the first time
The enzyme activity of echinocandin B improves 2.5 times compared with wild type AuEBDA, catalytic efficiency kcat/KmImprove 2.9 times.
Technical background
In recent years, fungal infection seriously threatens the life and health of the mankind, especially deep fungal infection.According to statistics, in Europe
The 70% of continent fungal infection death is related with Aspergillus, monilial infection.By the death of aggressive monilial infection
Rate is up to 30%, and in the case where cannot get timely and effective treatment, lethality is close to 100%.
The echinocandin class drugs such as anidulafungin (anidulafungin, Fig. 1), Caspofungin (caspofungin) are new
Generation antifungal drug, belongs to Cyclic lipopeptide antibiotic, is made of cyclic hexapeptide parent nucleus and fatty acid side chain structure two parts.Spine
The action target spot of white bacteriums drug is β -1, and 3- glucan synthase hinders fungi thin by the Noncompetition inhibition enzymatic activity
The synthesis of cell wall inhibits fungal cell's proliferation.Echinocandin B (echinocandin B, ECB) is Eurotium
The secondary metabolite of the fungies such as Aspergilusnidulans, Aspergilusrugulosus, hydrolysis ECB amido bond removal
The ECB parent nucleus (echinocandin B nucleus, ECBN) obtained after side-chain structure is synthesis anidulafungin, Caspofungin etc.
The critical materials of semisynthetic antibiotics.
Anidulafungin is mainly used for treating candida infection disease, and antifungal activity is than amphotericin B, Fluconazole etc.
By force, and its action target spot is single-minded, toxic side effect is low.Anidulafungin synthesis technology is divided into three phases: 1. aspergillus fermentation preparation
Echinocandin B raw material;2. the hydrolysis of echinocandin B amido bond obtains ECBN, this step reaction is catalyzed by ECB deacylase to be completed;③
ECBN again with
1-({[4″-(pentyloxy)-1,1′:4′,1″-terphenyl-4-yl]carbonyl}oxy)-1H-1,2,3-
Benzotriazole is acylated in dimethylformamide (DMF) to generate product anidulafungin.Wherein, ECB deacylase is catalyzed
ECB hydrolysis is the key that entire technique rate-determining steps, and therefore, implementing molecular modification to ECB deacylase has important science
Meaning and industrial value.
ECB deacylase is a kind of embrane-associated protein of amido bond between specific for hydrolysis ECBN and side chain in the present invention,
By the inactive Precursor Peptide of structural gene coding through post translational processings such as excision signal peptide, spacer peptides at α, β subunit, and just
Really it is folded into heterodimer α β.
In early-stage study, we are successful from actinoplanes utahensis (Actinoplanes utahensis) ZJB-
The deacylase AuEBDA that can be catalyzed the hydrolysis of ECB acyl side-chain is excavated to one in 08196, its encoding gene auebda is inserted into
Then pSET152 plasmid adds erythromycin strong promoter PermE* in gene front end, constructs constitutive expression plasmid pSET152-
PermE*-auebda realizes the auebda composing type in muta lead mycillin (Streptomyces lividans) TK24 point
Secrete expression.But the ECB deacylase of the muta lead mycillin secreting, expressing of building haves the defects that enzyme activity is low, it is still necessary to pass through egg
The catalytic performance of white matter engineering technology raising enzyme.
The present invention determines the space structure of AuEBDA using technological means such as bioinformatics, homologous modeling and molecular simulations
As constructing Streptomyces lividansTK24 mutant and analyzing the space structure of AuEBDA, near enzymatic activity pocket
Amino acid residue and the entrance of possible substrate, product release channel etc., pass through protein engineering and improve ECB deacylation base
Catalysis activity and substrate tolerance of the enzyme to echinocandin B.
The present invention is using the molecular docking of ECB and parent AuEBDA as a result, choosing the amino acid position near enzymatic activity pocket
Point, and rite-directed mutagenesis is carried out to it, screening obtains two plants of direct mutation sites, respectively G287Q and R527V.The present invention will
G287Q, R527V are combined mutation, obtain the deacylase gene that enzymatic activity is further promoted.
The present invention provides a kind of ECB deacylase renovation technique, building mutated gene, muta lead mycillin expression vector and
Engineering bacteria is simultaneously applied to the synthesis of ECBN biocatalysis.
Summary of the invention
Object of the present invention is to the enzyme activity of the ECB deacylase for existing maternal muta lead mycillin secreting, expressing it is low this
Defect provides a kind of recombination echinocandin B deacylase mutant for the first time, utilizes the gene recombination bacterium of the deacylase mutant
Or enzyme solution synthesizes ECBN as biocatalyst.
The technical solution adopted by the present invention:
The present invention provides a kind of recombination echinocandin B deacylase mutant, and the deacylase mutant is by SEQ
The 287th, 527 progress single mutation of amino acid sequence shown in ID No.2 or double mutation obtain;Shown in the SEQ ID No.2
The nucleotides sequence of amino acid AuEBDA encoding gene auebda is classified as shown in SEQ IDNo.1.
Further, the preferably described recombination echinocandin B deacylase mutant is one of following: (1) AuEBDA-G287Q,
The 287th glycine mutation of amino acid sequence shown in SEQ ID No.2 is glutamine, and encoding gene is labeled as auebda-
G287Q;(2) the 527th arginine of amino acid sequence shown in AuEBDA-R527V, SEQ ID No.2 sports valine, coding
Genetic marker is auebda-R527V;(3) amino acid sequence the 287th shown in AuEBDA-G287Q/R527V, SEQ ID No.2
Glycine mutation is glutamine, and the 527th arginine sports valine, and encoding gene is labeled as auebda-G287Q/
R527V。
Deacylase parent AuEBDA and deacylase mutant AuEBDA-G287Q, AuEBDA-R527V of the invention and
AuEBDA-G287Q/R527V base sequence overall length is 2364bp, is stopped from the 1st base to the 2364th base, is originated close
Numeral is GTG, and terminator codon TGA, G+C content is 72.1%.
The invention further relates to encoding gene, recombinant vector and the engineering bacteria structures of recombination echinocandin B deacylase mutant
It builds.It is preferred that recombinant expression carrier pSET152 (BioVector NTCC Inc.Beijing);The preferred lead-changing penicillium strepto- of host cell
Bacterium (Streptomyces lividans) TK24 (building and application study of State of Zhao's tinkling of pieces of jade echinocandin deacylase genetic engineering bacterium
[J] Chinese biological engineering magazine 2015,35 (1): 67-74.).Engineering bacteria construction method are as follows: by deacylase mutant code
Gene is connect with strong constitutive promoter PermE*, and is connected to expression plasmid pSET152, and conversion enters E.coli JM109 and feels
By state, deacylase mutant Escherichia coli cloning vector is obtained, extracts plasmid;The recombinant plasmid transformed of acquisition is entered
E.coli ET12567 competence obtains engagement transfer E. coli cloning vector;Engagement transfer imports muta lead mycillin
TK24 spore suspension is coated on containing 30 mMs of every liter of MgCl2MS solid medium on, deacylase mutant gene is whole
It is bonded on muta lead mycillin TK24 genome, obtains the engineering bacteria of the mutant gene containing deacylase.
It is white in biocatalysis ECB synthesis spine that the present invention also provides a kind of recombination echinocandin B deacylase mutant
Application in rhzomorph B parent nucleus (echinocandin B nucleus, ECBN), the specific application method are as follows: recombination will be contained
The deacylase mutant that the supernatant that the fermented culture of the engineering bacteria of echinocandin B deacylase mutant gene obtains extracts
Pure enzyme is constituted reaction system by cosolvent of methanol using ECB as substrate for catalyst, in 35 degrees Celsius, 600 rpms of items
It is reacted under part, reaction terminates, and reaction solution isolates and purifies, and obtains ECBN.
The catalyst is prepared as follows: the fermented culture of the engineering bacteria of the mutant gene containing deacylase is obtained
Supernatant with 1 mole of every liter of KH2PO4Adjust pH to 7.5, as crude enzyme liquid;Crude enzyme liquid is successively used microfiltration membranes, ultrafiltration membrane and
Nanofiltration membrane is filtered, and takes the filtrate of nanofiltration membrane dialysed overnight in 7.5,20 mMs of every liter of kaliumphosphate buffers of pH;
Bio-Rad HighS strong cat ion exchange column (first being balanced with pH7.5,20 mMs of every liter of kaliumphosphate buffers) in permeate,
Foreign protein is eluted with 0.1 mole of every liter of KCl aqueous solution again, is finally eluted with 0.2 mole of every liter of KCl aqueous solution, flow velocity is 1 milliliter
Per minute, when destination protein peak occurs in Protein Detection device, destination protein is collected, until the collection of destination protein peak is completely,
Dialysed overnight in pH7.5,20 mMs of every liter of kaliumphosphate buffers takes permeate, obtains the pure enzyme solution of deacylase, is as catalyzed
Agent.
Further, in the reaction system, final concentration of 0.1-1.5 mMs every liter of ECB, 1.00~5.02U/ of enzyme dosage
ML, methanol volumetric concentration are 5% (v/v).
Further, the fermentation liquid is prepared as follows: the engineering bacteria of the mutant gene containing deacylase is inoculated into
In the seed culture medium of the 25 micrograms per millilitre Pristinamycin containing final concentration, 28 degrees Celsius, 200 rpms are cultivated 3 days, as one
Grade seed culture fluid;Be inoculated into the inoculum concentration of volumetric concentration 10% in fresh seed culture medium, 28 degrees Celsius, 200 turns it is every
Minute culture 2 days, as secondary seed culture solution;Fresh fermentation medium is inoculated into the inoculum concentration of volumetric concentration 10%
In, 30 degrees Celsius, 200 rpms are cultivated 2.5 days, and 4 degrees Celsius, 8000 rpms are centrifuged 10 minutes, obtain supernatant;Institute
State seed culture medium composition are as follows: peptone 10g/L, yeast extract 10g/L, NaCl 0.5g/L, KH2PO4 1g/L、
K2HPO4·3H2O1.5g/L uses H3PO4PH to 7.0 is adjusted with KOH, solvent is deionized water;The fermentation medium composition: egg
White peptone 10g/L, yeast extract 10g/L, glucose 10g/L, NaCl 0.5g/L, KH2PO4 1g/L、K2HPO4·3H2O
1.5g/L uses H3PO4PH to 7.0 is adjusted with KOH, solvent is deionized water.The molecular modification of ECB deacylase reported in the literature
Mainly in promoter screening, signal peptide screening and increase gene copy number, it is intended to increase the expression quantity and secretory volume of albumen, but imitate
Fruit is general.
Compared with prior art, beneficial effect of the present invention is mainly reflected in: the present invention passes through mutation auebda gene order,
The conformation for changing AuEBDA primary structure and enzyme, improves the catalytic performance of AuEBDA.Present system analyze G287Q and
R527V replaces on the active influence of ECB deacylase.The enzyme activity for the double-mutant AuEBDA-G287Q/R527V that the present invention constructs is
2.5 times of parent enzyme wild type AuEBDA enzyme activity, catalytic efficiency kcat/KmImprove 2.9 times.
Detailed description of the invention
Fig. 1 is ECBN and anidulafungin synthesis technology.
Fig. 2 is Streptomyces lividansTK24/pSET152-PermE*-gene expression vector plasmid map.
The restriction enzyme site at ECB deacylase mutant gene sequence both ends is EcoR I/Xba I, and plasmid designations are respectively
pSET152-PermE*-auebda、pSET152-PermE*-auebda-G287Q、pSET152-PermE*-auebda-R527V
And pSET152-PermE*-auebda-G287Q/R527V.
Fig. 3 is positive colony PCR verifying.M: standard nucleic acid molecules amount;Swimming lane 1: host Streptomyceslividans
The 16SrRNA gene of TK24;Swimming lane 2:Streptomyces lividans TK24-auebda gene;Swimming lane 3:
Streptomyces lividans TK24/pSET152-PermE*-auebda 16SrRNA gene;Swimming lane 4:
Streptomyces lividans TK24/pSET152-PermE*-auebda gene;Swimming lane 5:Streptomyces
Lividans TK24/pSET152-PermE*-auebda-G287Q mutant 16S rRNA gene;Swimming lane 6:
Streptomyces lividans TK24/pSET152-PermE*-auebda-G287Q mutant auebda gene.Swimming lane 7:
Streptomyces lividans TK24/pSET152-PermE*-auebda-R527V mutant 16S rRNA gene;Swimming lane
8:Streptomyces lividans TK24/pSET152-PermE*-auebda-R527V mutant auebda gene.Swimming lane
9:Streptomyceslividans TK24/pSET152-PermE*-auebda-G287Q/R527V mutant 16SrRNA base
Cause;Swimming lane 10:Streptomyces lividans TK24/pSET152-PermE*-auebda-G287Q/R527V mutant
Auebda gene.
Fig. 4 is that WT-AuEBDA, AuEBDA-G287Q, AuEBDA-R527V and AuEBDA-G287Q/R527V catalysis ECB are de-
Acyl group efficiency.
Influence of Fig. 5 AuEBDA-G287Q/R527V enzyme dosage to ECB deacylation base synthesis ECBN.
Influence of Fig. 6 substrate additive amount to AuEBDA-G287Q/R527V catalysis ECB deacylation base synthesis ECBN.
Fig. 7 is pH value on the active influence of deacylase mutant AuEBDA-G287Q/R527V, and experimental material is using pure
Change enzyme.
Fig. 8 is deacylase mutant AuEBDA-G287Q/R527V pH stability, and experimental material is using purifying enzyme.
Fig. 9 is temperature on the active influence of deacylase mutant AuEBDA-G287Q/R527V, and experimental material is using pure
Change enzyme.
Figure 10 is deacylase mutant AuEBDA-G287Q/R527V thermal stability, and experimental material is using purifying enzyme.
Specific embodiment
Involved culture medium prescription is as follows in example:
LB liquid medium: peptone 10g/L, yeast extract 5g/L, NaCl 10g/L, solvent are deionized water, pH
7.0。
LB solid medium: peptone 10g/L, yeast extract 5g/L, NaCl 10g/L, agar powder 20g/L, solvent are
Deionized water uses H3PO4PH to 7.0 is adjusted with KOH.
Synthesize V solid medium: soluble starch 20g/L, beef extract 1g/L, K2HPO4·3H2O 0.5g/L、NaCl
0.5g/L、FeSO4 0.01g/L、KNO3 1.0g/L、MgSO40.5g/L, agar 24.0g/L, use H3PO4With KOH adjust pH to
7.0, solvent is deionized water.
MS culture medium: soybean powder 20.0g/L, mannitol 20.0g/L, agar 20.0g/L, solvent are deionized water, pH value
It is natural.
Seed culture medium: peptone 10g/L, yeast extract 10g/L, NaCl 0.5g/L, KH2PO4 1g/L、
K2HPO4·3H2O 1.5g/L, uses H3PO4PH to 7.0 is adjusted with KOH, solvent is deionized water.
Fermentation medium: peptone 10g/L, yeast extract 10g/L, glucose 10g/L, NaCl0.5g/L, KH2PO4
1g/L、K2HPO4·3H2O 1.5g/L, uses H3PO4PH to 7.0 is adjusted with KOH, solvent is deionized water.
Embodiment 1: homologous modeling and molecular docking
To the deacylation base that sets out in SWISS-MODEL database (https: //www.swissmodel.expasy.org/)
(shown in SEQ ID No.2, encoding gene auadea nucleotides sequence is classified as SEQ ID No.1 institute to the amino acid sequence of enzyme AuEBDA
Show) it is compared.The homologous highest model protein of degree is derived from the antibiotic acyltransferase of Acidovoraxsp.MR-S7
MacQ (PDB ID:5C9i_1), amino acid sequence and deacylase AuEBDA homology of setting out are 40.77%.
Program coding is carried out with 9.14 software of Modeller, using MacQ protein sequence as template, constructs AuEBDA egg
The three-dimensional space model of Bai Xulie obtains best model.It is subsequent to use ChemDraw Software on Drawing and convert substrate ECB three-dimensional mould
Type carries out molecular docking using 4.2 software of AutoDock.Using Pymol1.6.0.0 carry out analysis albumen and substrate molecule it
Between three-dimensional structure relationship.
By sequence alignment, Gln259 corresponding to the site Gly287 and the MacQ albumen in AuEBDA albumen is found not
Together.Molecular docking is carried out using AutoDock software, it is found that the R527 site side chains near enzyme activity pocket are larger, there are space bits
Inhibition effect, therefore, R527 may have more consequence to enzymatic structure.The G287 of AuEBDA albumen is mutated into Q
(AuEBDA-G287Q), R527 is mutated into V (AuEBDA-R527V), the G287 of AuEBDA albumen is mutated into Q and is mutated R527
At V (AuEBDA-G287Q/R527V).With 9.14 software of Modeller using MacQ protein sequence as template, building
The three-dimensional space model of AuEBDA mutain.
The results show that AuEBDA mutant protein molecules are larger, and original AuEBDA enzyme active center catalytic pocket is smaller, phase
For G, the Q in 287 sites has biggish side chain after mutation, has a certain impact to the structure tool of enzyme, so that the knot of enzyme pocket
Structure becomes larger, so that reducing substrate enters the space resistance of holoenzyme molecular activity pocket or the space resistance of product release.This
Outside, compared to parent's AuEBDA albumen, the valine of R527V mutant is hydrophobic amino acid, to the affine enzyme activity pocket of substrate
Positive effect is played, furthermore forms hydrogen bond on S525 and substrate, the increase of hydrogen bond is so that the combination of substrate and enzyme produces actively
It influences.
Embodiment 2:PCR method constructs E. coli cloning vector
1, pSET152-auebda plasmid
Will travelling Utah actinomyces Actinoplanes utahensis ZJB-08196 (Wang Y J, Liu L L,
Feng Z H,et al.Optimization of media composition and culture conditions for
acarbose production by Actinoplanes utahensis ZJB-08196[J].World Journal of
Microbiology&Biotechnology, 2011,27 (12): 2759-2766.) in the synthesis V solid medium of non-resistant
On carry out scribing line activation, picking single bacterium is fallen in the seed culture medium of non-resistant, 28 degrees Celsius, 200 rpms cultivate 3 days,
Travelling Utah actinomyces ZJB-08196 thallus is obtained, genome is extracted.Using the genome of extraction as amplification template, in gene
EcoR I and Xba I restriction enzyme site are added in the both ends of sequence, and PCR amplification is carried out using auebda-F and auebda-R as primer
(amplification system and condition are shown in Tables 1 and 2), amplified production are the gene auebda that sets out.
Primer sequence is as follows:
Auebda-F:5 '-GAATTCGTGACGTCCTCG-3’
Auebda-R:5 '-TCTAGATCAGCGTCCCCG-3’
Double digestion is carried out to pSET152 plasmid simultaneously, then by the digestion products for gene auebda and the pSET152 plasmid that sets out
Connection, conversion enter E.coli JM109, are coated on LB plate (containing 25 micrograms per millilitre Pristinamycins), 37 degrees Celsius
Overnight incubation carries out bacterium colony PCR to positive clone molecule, and extracts plasmid order-checking verifying, obtains pSET152-auebda plasmid.
2, plasmid pSET152-PermE*-auebda
EcoR I restriction enzyme site is added at the both ends of strong constitutive promoter PermE* sequence, expands PermE*.Amplification is anti-
Condition such as table 3 is answered, primer sequence is as follows:
PermE*-F:5 '-GAATTCGTGCACGCGGTCG-3’
PermE*-R:5 '-GAATTCCGCTGGATCCTAC-3’
Simultaneously to pSET152-auebda plasmid carry out EcoR I single endonuclease digestion, 37 degrees Celsius digestion 6 hours, 65 degrees Celsius guarantor
Temperature 10 minutes inactivates EcoR I enzyme.The digestion products of PermE* and pSET152-auebda plasmid T4 ligase is connected again
It connects, overnight, conversion imports E.coli JM109 for 37 degrees Celsius of connections, enterprising in LB plate (containing 25 micrograms per millilitre Pristinamycins)
Row coating, 37 degrees Celsius of overnight incubations carry out bacterium colony PCR to positive clone molecule, and extract plasmid pSET152-PermE*-
Auebda sequence verification chooses gene bacterial strain in the right direction.Plasmid map is shown graphically in the attached figures 2.
3, rite-directed mutagenesis
Using plasmid pSET152-PermE*-auebda as template, using the method for rite-directed mutagenesis respectively by Parent Protease
AuEBDA (shown in SEQ ID NO.2) the 287th site glycine rite-directed mutagenesis is at glutamine, the 527th site arginine fixed point
It is mutated into valine, and carries out combinatorial mutagenesis, obtains mutant pSET152-PermE*-auebda-G287Q, pSET152-
The amplified production of PermE*-auebda-R527V and pSET152-PermE*-auebda-G287Q/R527V, the same table of amplification system
1, amplification condition such as table 4.Primer sequence is as follows:
G287Q-F:5 '-GCGACCCGATCATCCAGATCGGGCACAAC-3 '
G287Q-R:5 '-GTTGTGCCCGATCTGGATGATCGGGT-3 '
R527V-F:5 '-CGCGCAGCCTGGTCACCCGGCTC-3 '
R527V-R:5 '-GAGCCGGGTGACCAGGCTGCGCG-3 '
Amplified production is first subjected to digestion original template with DpnI enzyme, then is converted into E.coli JM109, then micro- containing 25
Gram every milliliter of Pristinamycin resistance LB plate is coated, 37 degrees Celsius of overnight incubations.Bacterium colony PCR is carried out to positive clone molecule,
And extract plasmid order-checking verifying.Plasmid pSET152-PermE*-auebda-G287Q, pSET152-PermE*- are obtained respectively
Auebda-R527V and pSET152-PermE*-auebda-G287Q/R527V.
PCR praises Phanta Max kit using Novi, and amplification reaction system (μ L) is as follows:
1 amplification reaction system of table
Table 2 expands auebda segment reaction condition
Table 3 expands PermE* segment reaction condition
4 rite-directed mutagenesis amplification reaction condition of table
Embodiment 3: muta lead mycillin expression vector establishment
1, the plasmid conversion in embodiment 2 is entered into E.coli ET12567/pUZ8002, picking positive clone molecule respectively
Single bacterium is fallen within containing 10 milliliters of LB culture mediums (containing 50 micrograms per millilitre kanamycins, 25 micrograms per millilitre chloramphenicol, the every milli of 25 micrograms
Rise Pristinamycin) in test tube, 37 degrees Celsius, 200 rpms of overnight incubations.Bacterium solution is overnight with the inoculum concentration of volumetric concentration 1%
It is transferred in 50 milliliters of LB liquid mediums containing corresponding antibiotic, 37 degrees Celsius, 200 rpms are cultivated 6 to 8 hours, are made
OD600Reach 0.4~0.6.It is washed 2 times with isometric sterile LB medium, then with 0.5 milliliter of fresh sterile LB medium
It suspends, as E.coli suspension, measures E.coli concentration with blood counting chamber.
2, muta lead mycillin spore suspension is prepared.To host's muta lead mycillin Streptomyces
LividansTK24 crosses on synthesis V solid medium, 28 degrees Celsius, cultivates 7 days or so, when spore growth is plentiful,
It performs the following operation:
(1) 10 milliliters of sterile waters are added on inclined-plane;
(2) spore is gently scraped with spreading rod, makes spore suspension in sterile water;
(3) spore suspension is poured into 10 milliliters of centrifuge tubes containing bead, puts to vibrate 1 minute or so on the oscillator and fills
Divide and breaks up spore;
(4) suspension is filtered with the funnel equipped with sterile absorbent cotton, removes mycelium and solid culture based draff;
(5) 6000 rpms of centrifugations precipitate spore in 10 minutes;
(6) supernatant is outwelled, adds a little sterile water that spore is resuspended;
(7) it is 30% glycerine water solution that sterile volumetric concentration, which is added, in the ratio with volume ratio for 1:1, as
Streptomyces lividans TK24 spore suspension, final glycerol concentration 15% measure spore concentration with blood counting chamber
Afterwards, -80 DEG C of freezings.
3, engagement transfer.500 microlitres of LB of Streptomyces lividans TK24 spore suspension prepared by step 2
Fluid nutrient medium washs 2 times, by spore suspension in 500 microlitres of LB liquid mediums, then 50 C water bath's Heat thermostability
10 minutes, room temperature natural cooling.By the Streptomyces lividans TK24 spore of step 1 escherichia coli suspension and step 2
Sub- suspension is 10 by concentration ratio8:106Ratio mixing, 6000 rpms of centrifugations suck most of supernatant after five minutes, to remain
Again suspension thalline precipitates liquid, and is coated on MS plate and (contains 30 mMs of every liter of MgCl2).30 degrees Celsius of cultures 16 to 20
Hour, by 1 milliliter of sterile water uniform fold containing 50 microgram nalidixic acids and 50 microgram Pristinamycins in planar surface.To dry
Afterwards, it is cultivated in 28 degrees Celsius of inversions.After 3 to 5 days, screening positive clone.Need to carry out multiple single colonie purifying when necessary.Point
Not Huo get the mutant gene of deacylase containing ECB recombination muta lead mycillin: Streptomyces lividans TK24/
pSET152-PermE*-auebda、Streptomyces lividans TK24/pSET152-PermE*-auebda-G287Q、
Streptomyces lividans TK24/pSET152-PermE*-auebda-R527V and Streptomyces lividans
TK24/pSET152-PermE*-auebda-G287Q/R527V。
Embodiment 4: the recombination muta lead mycillin positive strain verifying of the mutant gene of deacylase containing ECB
The weight of 4 plants of mutant genes of deacylase containing ECB of acquisition is constructed in picking muta lead mycillin TK24 and example 3
Group muta lead mycillin positive clone molecule single colonie (totally 5 plants), until boiling after twenty minutes in 20 microlitres of sterile waters as template.
Using target gene auebda both ends gene order as primer, amplifying target genes.It is lead-changing penicillium strepto- to verify the bacterial strain
Bacterium is expanded, segment using the 16SrRNA genetic fragment of Streptomyces lividans TK24 as template design primer
For 500bp.In addition to it can not amplify target gene fragment in control group Streptomyces lividans TK24, if remaining
Target gene and 16S rRNA fragment gene can be amplified respectively, then are otherwise false positive to construct successfully.Primer sequence is such as
Under:
Primer-F:ACGTCCTCGTACATGCGCCTGAAAGC
Primer-R:TCAGCGTCCCCGCTGTGCCACCCGG
S-16S-rRNA-F:TGGCAACACGGGACAAGGGT
S-16S-rRNA-R:CCGTCACTTTCGCTTCTTCC
PCR praises Phanta Max kit using Novi, and amplification reaction system is as follows:
It is as follows to expand auebda segment reaction condition:
It is as follows to expand 500bp segment reaction condition in 16SrRNA:
Then agarose nucleic acid electrophoresis is carried out, electrophoresis result is as shown in Figure 3.And sequence verification is carried out, host is obtained respectively to be become
Lead blueness streptomycete and recombination muta lead mycillin expression vector positive strain: Streptomyces lividansTK24/
pSET152-PermE*-auebda、Streptomyces lividans TK24/pSET152-PermE*-auebda-G287Q、
Streptomyces lividans TK24/pSET152-PermE*-auebda-R527V and Streptomyces lividans
TK24/pSET152-PermE*-auebda-G287Q/R527V。
Embodiment 5: recombination muta lead mycillin producing enzyme culture
The recombination muta lead mycillin bacterium colony constructed in about 1 square centimeter of size embodiment 4 is selected respectively in 30 milliliters of kinds
(contain 25 micrograms per millilitre Pristinamycins) in sub- culture medium, 28 degrees Celsius, 200 rpms are cultivated 3 days, as first order seed
Liquid.Be forwarded in 30 milliliters of antibiotic seed culture mediums with the inoculum concentration of volumetric concentration 10%, 28 degrees Celsius, 200 turns it is every
Minute culture 2 days, as secondary seed solution.30 milliliters of antibiotic fermentation trainings are forwarded to the inoculum concentration of volumetric concentration 10%
It supports in base, 30 degrees Celsius, 200 rpms are cultivated 2.5 days.Fermentation liquid is collected, 8000 rpms of centrifugations must be sent out after ten minutes
Ferment stoste, with 1 mole of every liter of KH2PO4PH to 7.5 is adjusted, obtains deacylase AuEBDA crude enzyme liquid, deacylase mutant respectively
AuEBDA-G287Q crude enzyme liquid, deacylase mutant AuEBDA-R527V crude enzyme liquid, deacylase mutant AuEBDA-
G287Q/R527V crude enzyme liquid.
Embodiment 6: recombination muta lead mycillin deacylase purifying
Crossing aperture to deacylase crude enzyme liquid in embodiment 5 respectively is 0.2 micron, the micropore filtering film that diameter is 50 millimeters
Mycelium and impurity in fermentation liquid are removed, collects micro-filtrate, micro-filtrate volume is identical with crude enzyme liquid volume at this time.By micro-filtrate mistake
10kDa ultrafiltration membrane is concentrated by ultrafiltration, and as 1/10th of enzyme solution volume remaining in ultrafiltration system to initial volume, is stopped
Ultrafiltration, enzyme solution is ignored in ultrafiltration system pipeline, collects ultrafiltrate, ultrafiltrate at this time, which is equivalent to, concentrates 10 times.Ultrafiltration
Liquid carry out nanofiltration, nanofiltration specification be 10kDa, 4000 rpms be centrifuged 30 minutes, collect nanofiltration pipe in enzyme solution, with pH7.5,
20 mMs of every liter of kaliumphosphate buffer polishing enzyme solution volumes are to 0.1 times of ultrafiltrate volume, and nanofiltration liquid is equivalent to concentration at this time
General times are 100 times, obtain nanofiltration liquid.All steps operate in ice bath.By nanofiltration liquid at 7.5,20 mMs every liter of pH
Dialysed overnight, the Bio- balanced in permeate through pH7.5,20 mMs of every liter of kaliumphosphate buffers are carried out in kaliumphosphate buffer
Rad HighS strong cation exchange gel column elutes foreign protein with 0.1 mole of every liter of KCl aqueous solution, with 0.2 mole of every liter of KCl
Aqueous solution elutes destination protein.Flow velocity is 1 milliliter per minute, when destination protein peak occurs in Protein Detection device, collects purpose egg
It is white, until destination protein peak terminates.By elution under destination protein in 7.5,20 mMs of every liter of kaliumphosphate buffers of pH into
Row dialysed overnight takes permeate, obtains the pure enzyme solution of deacylase AuEBDA, the pure enzyme of deacylase mutant AuEBDA-G287Q respectively
Liquid, the pure enzyme solution of deacylase mutant AuEBDA-R527V, the pure enzyme solution of deacylase mutant AuEBDA-G287Q/R527V.Root
According to the concentration of standard Bradford measuring method measurement protein purification.
Embodiment 7: deacylase enzyme activity determination
Enzyme-activity unit definition: under the conditions of 35 degrees Celsius, 7.5 pH, every liter of product ECBN institute of 1 micromole is generated per minute
The enzyme amount needed is defined as 1 enzyme-activity unit (U).
The pure enzyme solution of deacylase in Example 6 is catalyst respectively, is 5% with volumetric concentration using ECB as substrate
Methanol constitutes reaction system as cosolvent.It takes 4.75 milliliters of pure enzyme solutions to be placed under 35 degrees celsius and keeps the temperature 5 minutes, be added
ECB makes final concentration of 1.0 gram per liters, and 250 microlitres of methanol are cosolvent.It is carried out under the conditions of 35 degrees Celsius, 600 rpms anti-
It answers, reaction takes 200 microlitres of reaction solutions after ten minutes, and 200 microlitres of anhydrous methanols are added immediately and terminate and react, 12000 rpms
Centrifugation 5 minutes, takes supernatant.Using HPLC analysis detection enzyme activity, analysis is repeated 3 times.As a result as shown in Fig. 4, AuEBDA's
Specific enzyme activity is 152.3U/mg, the specific enzyme activity of mutant AuEBDA-G287Q is 212.1U/mg, mutant AuEBDA-R527V
Specific enzyme activity is 310.1U/mg, the specific enzyme activity of mutant AuEBDA-G287Q/R527V is 380.8U/mg, mutant AuEBDA-
The specific enzyme activity of G287Q/R527V improves 2.5 times compared with parent enzyme AuEBDA.
In addition, the present invention also constructs other 5 plant mutant body using molecular docking, be negative mutant, specific building side
Method such as Examples 1 to 66, specific enzyme activity is as follows: mutant AuEBDA-G340S is 136.9U/mg, mutant AuEBDA-G340I
For 148.3U/mg, mutant AuEBDA-F254G be 136.9U/mg, mutant AuEBDA-F254W is 140.5U/mg and mutation
Body AuEBDA-F254Y is 128.2U/mg.Enzyme activity calculation formula is as follows:
Wherein cECBNIt is the concentration of ECBN in the reaction system, g/L;React total system, 5mL;N is extension rate;Reaction
Time, 10min;4.75mL enzyme preparation additive amount;808 be the molal weight of ECBN, g/mol.
2, ECB and ECBN detection method
ECB and ECBN is detected with the method for HPLC.HPLC model selects Agilent 1260infinity II, USA, purple
External detector model 1260DAD WR.Chromatographic column is C18 column (4.6 × 250mm, 5 μm, Welchrom, Shanghai).Column temperature is kept
At 40 degrees Celsius.By solvent A (2 gram per liters of ammonium acetate solutions) and solvent B, (2 gram per liters of ammonium acetate solutions, solvent are body to mobile phase
Product 60% acetonitrile solution of concentration) composition.C18Column is balanced each other by the flowing that 92% solvent A and 8% solvent B are formed, elution program
As follows: from 0 minute to 15 minute, linear gradient is from 92%A → 8%B to 2%A → 98%B;From 15 minutes to 26 minute, linearly
Gradient is from 2%A → 98%B to 8%A → 92%B;From 25 minutes to 33 minute, constant ratio is 92%A → 8%B.Mobile phase
With 0.8 milliliter of flow velocity operation per minute.The retention time of ECBN and ECB is respectively 6.3 minutes and 26.1 minutes.Using identical
Method measurement ECB concentration and draw standard curve, calibration curve equation are as follows: y=4917.0x-33.36, R2=0.999.
Embodiment 8: deacylase mutant AuEBDA-G287Q/R527V catalytic condition optimization
This example determines deacylase mutant AuEBDA-G287Q/R527V in different enzyme amount, different concentration of substrate
Under the conditions of, catalysis ECB generates the catalytic efficiency of ECBN.It is reacted under the conditions of 35 degrees Celsius, pH7.5, reaction total system is 5
Milliliter, final concentration of 1.0 gram per liters of ECB, methanol volumetric concentration is 5% (v/v).
Enzyme amount range is 1.00~5.02U/mL, uses 7.5,20 mMs of every liter of kaliumphosphate buffer polishing enzymes of pH respectively
Liquid product is to 4.75 milliliters.It is sampled respectively when reacting the different time points between 5 minutes to 12 hours.As a result such as attached drawing 5, when
When enzyme additive amount is 5.02U/mL, reaction reaches balance after 7 hours, and the conversion ratio after reaction 12 hours is 80%.Enzyme additive amount
When respectively 4.01U/mL and 3.01U/mL, reach balance after reacting 8 hours and 10 hours respectively.When enzyme additive amount is respectively
When 2.00U/mL and 1.00U/mL, after reaction 12 hours, conversion ratio is respectively 72% and 56%.
Concentration of substrate selects 0.50,0.75,1.00,1.25 and 1.50 mM every liter respectively, and enzyme additive amount is
5.02U/mL.It is sampled respectively when reacting the different time points between 5 minutes to 12 hours.As a result as shown in fig. 6, when substrate is dense
When degree is respectively 0.50 and 0.75 mM every liter, reaction reaches balance behind 1 hour and 7 hours respectively, and conversion ratio is
100%.When ECB concentration is 1.00 mMs every liter or more, reaction reaches balance, the production quantity of ECBN after 8 hours
At 0.76 mM or so, and difference is unobvious within 12 hours.
Embodiment 9: deacylase mutant AuEBDA-G287Q/R527V kinetics
This example determines the reactive kinetics parameters of parent's deacylase AuEBDA and its mutant.35 degrees Celsius,
It is reacted under the conditions of pH 7.5.The dynamics ginseng of ECB is measured at the ECB (0.1~0.5 mM every liter) of various concentration
Number.And Michaelis constant K is estimated by the nonlinear fitting of general initial reaction ratemWith maximum reaction rate vmaxValue.Rice
Family name's equation is as follows:
As a result it is shown in table 5, at optimum conditions, the catalytic efficiency k of parent's deacylase AuEBDAcat/KmFor 11.26s-1·mM-1, mutant AuEBDA-G287Q catalytic efficiency is 18.38s-1·mM-1, mutant AuEBDA-R527V catalytic efficiency is
25.05s-1·mM-1, mutant AuEBDA-G287Q/R527V catalytic efficiency is 44.13s-1·mM-1.With parent's AuEBDA phase
Than the K of each mutantmReduce, catalytic efficiency kcat/KmIncrease separately 0.6 times, 1.2 times and 2.9 times.
The comparison of the stability kinetics parameter of 5 WT-AuEBDA of table and its mutant
Embodiment 10: deacylase mutant AuEBDA-G287Q/R527V reacts pH optimization and pH stability
The pure enzyme solution of the AuEBDA-G287Q/R527V that embodiment 6 is prepared, it is every with 1 mole of every liter of phosphoric acid and 1 mole
It rises potassium hydroxide and adjusts pH value to 5.0,5.5,6.0,6.5,7.0,7.5,8.0,8.5,9.0.The 4.75 of different pH value are taken respectively
The pure enzyme solution of milliliter, which is placed under 35 degrees Celsius, keeps the temperature 10 minutes, and ECB, which is added, makes final concentration of 1.0 gram per liters, and 250 microlitres of methanol are to help
Solvent, reaction total system are 5 milliliters, are reacted under the conditions of 35 degrees Celsius, 600 rpms, carry out enzyme activity determination (with real
Apply example 7).As a result as shown in fig. 7, in pH 7.5, specific enzyme activity highest reaches 380.8U/mg.
The pure enzyme solution of AuEBDA-G287Q/R527V is kept the temperature 0~12 hour under the conditions of pH5.5~9.0 respectively, Mei Geyi
The section time is measured enzyme activity.Fig. 8 the results show that deacylase mutant AuEBDA-G287Q/R527V in pH 7.0~9.0
It is with good stability in range.
Embodiment 11: the optimization of deacylase mutant AuEBDA-G287Q/R527V reaction temperature and temperature stability
Pipette the pure enzyme solution of AuEBDA-G287Q/R527V that 4.75mL embodiment 6 is prepared, respectively 20,25,30,
35,40,45 degrees Celsius shaking table reactor inside holding 10 minutes, ECB, which is added, makes final concentration of 1.0 gram per liters, and 250 microlitres of methanol are
Cosolvent, reaction total system are 5 milliliters, and 600 rpms are reacted 10 minutes, and enzyme activity is measured by sampling.As a result as shown in figure 9,
AuEBDA-G287Q/R527V enzyme activity highest at 35 degrees Celsius, specific enzyme activity reach 376.2U/mg.
Enzyme solution under the conditions of each temperature is kept the temperature 0~12 hour respectively, is measured enzyme activity at regular intervals.Mutant enzyme
Temperature stability be shown in Figure 10, AuEBDA-G287Q/R527V has very strong stability at low temperature.Its 4 degrees Celsius,
Remain to remain above 95% relative activity under the conditions of pH 7.5 after saving 15 days;It is saved under the conditions of 25 degrees Celsius, 7.5 pH
90% relative activity is still remained above after 12 hours;It saves 12 hours, remains above under the conditions of 35 degrees Celsius, 7.5 pH
80% relative activity.In addition, half-life period difference of the AuEBDA-G287Q/R527V under 45 degrees Celsius and 55 degrees celsius
For 28.1 hours and 4.3 hours.
Embodiment 12:EDTA and metal ion are on the active influence of deacylase mutant AuEBDA-G287Q/R527V
The pure enzyme solution of AuEBDA-G287Q/R527V that 4.75mL embodiment 6 is prepared is pipetted, final concentration is successively separately added
For 5 mMs of every liter of EDTA, heavy metal ion, such as Li+、Zn+、Mn2+、Mg2+、Fe3+、Ni2+And Cu2+, it is placed on 35 degrees Celsius of heat preservations
10 minutes, ECB, which is added, made final concentration of 1.0 gram per liters, and 5% (v/v) methanol is cosolvent, and reaction total system is 5 milliliters, and 600
It is reacted under the conditions of rpm, enzyme activity is measured by sampling after ten minutes.The results are shown in Table 6, AuEBDA-G287Q/R527V
Activity do not influenced by EDTA, show that AuEBDA-G287Q/R527V is not metalloenzyme.In addition, AuEBDA-G287Q/R527V
Activity do not influenced by metal ion.
The influence of 6 metal ion of table and EDTA to AuEBDA-G287Q/R527V enzyme activity
Sequence table
<110>Zhejiang Polytechnical University
<120>a kind of recombination echinocandin B deacylase mutant and application
<160> 2
<170> SIPOSequenceListing 1.0
<210> 1
<211> 2364
<212> DNA
<213>actinoplanes utahensis (Actinoplanes utahensis)
<400> 1
gtgacgtcct cgtacatgcg cctgaaagca gcagcgatcg ccttcggtgt gatcgtggcg 60
accgcagccg tgccgtcacc cgcttccggc agggaacatg acggcggcta tgcggccctg 120
atccgccggg cctcgtacgg cgtcccgcac atcaccgccg acgacttcgg gagcctcggt 180
ttcggcgtcg ggtacgtgca ggccgaggac aacatctgcg tcatcgccga gagcgtagtg 240
acggccaacg gtgagcggtc gcggtggttc ggtgcgaccg ggccggacga cgccgatgtg 300
cgcagcgacc tcttccaccg caaggcgatc gacgaccgcg tcgccgagcg gctcctcgaa 360
gggccccgcg acggcgtgcg ggcgccgtcg gacgacgtcc gggaccagat gcgcggcttc 420
gtcgccggct acaaccactt cctacgccgc accggcgtgc accgcctgac cgacccggcg 480
tgccgcggca aggcctgggt gcgcccgctc tccgagatcg atctctggcg tacgtcgtgg 540
gacagcatgg tccgggccgg ttccggggcg ctgctcgacg gcatcgtcgc cgcgacgcca 600
cctacagccg ccgggcccgc gtcagccccg gaggcacccg acgccgccgc gatcgccgcc 660
gccctcgacg ggacgagcgc gggcatcggc agcaacgcgt acggcctcgg cgcgcaggcc 720
accgtgaacg gcagcgggat ggtgctggcc aacccgcact tcccgtggca gggcgccgca 780
cgcttctacc ggatgcacct caaggtgccc ggccgctacg acgtcgaggg cgcggcgctg 840
atcggcgacc cgatcatcgg gatcgggcac aaccgcacgg tcgcctggag ccacaccgtc 900
tccaccgccc gccggttcgt gtggcaccgc ctgagcctcg tgcccggcga ccccacctcc 960
tattacgtcg acggccggcc cgagcggatg cgcgcccgca cggtcacggt ccagaccggc 1020
agcggcccgg tcagccgcac cttccacgac acccgctacg gcccggtggc cgtgatgccg 1080
ggcaccttcg actggacgcc ggccaccgcg tacgccatca ccgacgtcaa cgcgggcaac 1140
aaccgcgcct tcgacgggtg gctgcggatg ggccaggcca aggacgtccg ggcgctcaag 1200
gcggtcctcg accggcacca gttcctgccc tgggtcaacg tgatcgccgc cgacgcgcgg 1260
ggcgaggccc tctacggcga tcattcggtc gtcccccggg tgaccggcgc gctcgctgcc 1320
gcctgcatcc cggcgccgtt ccagccgctc tacgcctcca gcggccaggc ggtcctggac 1380
ggttcccggt cggactgcgc gctcggcgcc gaccccgacg ccgcggtccc gggcattctc 1440
ggcccggcga gcctgccggt gcggttccgc gacgactacg tcaccaactc caacgacagt 1500
cactggctgg ccagcccggc cgccccgctg gaaggcttcc cgcggatcct cggcaacgaa 1560
cgcaccccgc gcagcctgcg cacccggctc gggctggacc agatccagca gcgcctcgcc 1620
ggcacggacg gtctgcccgg caagggcttc accaccgccc ggctctggca ggtcatgttc 1680
ggcaaccgga tgcacggcgc cgaactcgcc cgcgacgacc tggtcgcgct ctgccgccgc 1740
cagccgaccg cgaccgcctc gaacggcgcg atcgtcgacc tcaccgcggc ctgcacggcg 1800
ctgtcccgct tcgatgagcg tgccgacctg gacagccggg gcgcgcacct gttcaccgag 1860
ttcgccctcg cgggcggaat caggttcgcc gacaccttcg aggtgaccga tccggtacgc 1920
accccgcgcc gtctgaacac cacggatccg cgggtacgga cggcgctcgc cgacgccgtg 1980
caacggctcg ccggcatccc cctcgacgcg aagctgggag acatccacac cgacagccgc 2040
ggcgaacggc gcatccccat ccacggtggc cgcggggaag caggcacctt caacgtgatc 2100
accaacccgc tcgtgccggg cgtgggatac ccgcaggtcg tccacggaac atcgttcgtg 2160
atggccgtcg aactcggccc gcacggcccg tcgggacggc agatcctcac ctatgcgcag 2220
tcgacgaacc cgaactcacc ctggtacgcc gaccagaccg tgctctactc gcggaagggc 2280
tgggacacca tcaagtacac cgaggcgcag atcgcggccg acccgaacct gcgcgtctac 2340
cgggtggcac agcggggacg ctga 2364
<210> 2
<211> 787
<212> PRT
<213>actinoplanes utahensis (Actinoplanes utahensis)
<400> 2
Val Thr Ser Ser Tyr Met Arg Leu Lys Ala Ala Ala Ile Ala Phe Gly
1 5 10 15
Val Ile Val Ala Thr Ala Ala Val Pro Ser Pro Ala Ser Gly Arg Glu
20 25 30
His Asp Gly Gly Tyr Ala Ala Leu Ile Arg Arg Ala Ser Tyr Gly Val
35 40 45
Pro His Ile Thr Ala Asp Asp Phe Gly Ser Leu Gly Phe Gly Val Gly
50 55 60
Tyr Val Gln Ala Glu Asp Asn Ile Cys Val Ile Ala Glu Ser Val Val
65 70 75 80
Thr Ala Asn Gly Glu Arg Ser Arg Trp Phe Gly Ala Thr Gly Pro Asp
85 90 95
Asp Ala Asp Val Arg Ser Asp Leu Phe His Arg Lys Ala Ile Asp Asp
100 105 110
Arg Val Ala Glu Arg Leu Leu Glu Gly Pro Arg Asp Gly Val Arg Ala
115 120 125
Pro Ser Asp Asp Val Arg Asp Gln Met Arg Gly Phe Val Ala Gly Tyr
130 135 140
Asn His Phe Leu Arg Arg Thr Gly Val His Arg Leu Thr Asp Pro Ala
145 150 155 160
Cys Arg Gly Lys Ala Trp Val Arg Pro Leu Ser Glu Ile Asp Leu Trp
165 170 175
Arg Thr Ser Trp Asp Ser Met Val Arg Ala Gly Ser Gly Ala Leu Leu
180 185 190
Asp Gly Ile Val Ala Ala Thr Pro Pro Thr Ala Ala Gly Pro Ala Ser
195 200 205
Ala Pro Glu Ala Pro Asp Ala Ala Ala Ile Ala Ala Ala Leu Asp Gly
210 215 220
Thr Ser Ala Gly Ile Gly Ser Asn Ala Tyr Gly Leu Gly Ala Gln Ala
225 230 235 240
Thr Val Asn Gly Ser Gly Met Val Leu Ala Asn Pro His Phe Pro Trp
245 250 255
Gln Gly Ala Ala Arg Phe Tyr Arg Met His Leu Lys Val Pro Gly Arg
260 265 270
Tyr Asp Val Glu Gly Ala Ala Leu Ile Gly Asp Pro Ile Ile Gly Ile
275 280 285
Gly His Asn Arg Thr Val Ala Trp Ser His Thr Val Ser Thr Ala Arg
290 295 300
Arg Phe Val Trp His Arg Leu Ser Leu Val Pro Gly Asp Pro Thr Ser
305 310 315 320
Tyr Tyr Val Asp Gly Arg Pro Glu Arg Met Arg Ala Arg Thr Val Thr
325 330 335
Val Gln Thr Gly Ser Gly Pro Val Ser Arg Thr Phe His Asp Thr Arg
340 345 350
Tyr Gly Pro Val Ala Val Met Pro Gly Thr Phe Asp Trp Thr Pro Ala
355 360 365
Thr Ala Tyr Ala Ile Thr Asp Val Asn Ala Gly Asn Asn Arg Ala Phe
370 375 380
Asp Gly Trp Leu Arg Met Gly Gln Ala Lys Asp Val Arg Ala Leu Lys
385 390 395 400
Ala Val Leu Asp Arg His Gln Phe Leu Pro Trp Val Asn Val Ile Ala
405 410 415
Ala Asp Ala Arg Gly Glu Ala Leu Tyr Gly Asp His Ser Val Val Pro
420 425 430
Arg Val Thr Gly Ala Leu Ala Ala Ala Cys Ile Pro Ala Pro Phe Gln
435 440 445
Pro Leu Tyr Ala Ser Ser Gly Gln Ala Val Leu Asp Gly Ser Arg Ser
450 455 460
Asp Cys Ala Leu Gly Ala Asp Pro Asp Ala Ala Val Pro Gly Ile Leu
465 470 475 480
Gly Pro Ala Ser Leu Pro Val Arg Phe Arg Asp Asp Tyr Val Thr Asn
485 490 495
Ser Asn Asp Ser His Trp Leu Ala Ser Pro Ala Ala Pro Leu Glu Gly
500 505 510
Phe Pro Arg Ile Leu Gly Asn Glu Arg Thr Pro Arg Ser Leu Arg Thr
515 520 525
Arg Leu Gly Leu Asp Gln Ile Gln Gln Arg Leu Ala Gly Thr Asp Gly
530 535 540
Leu Pro Gly Lys Gly Phe Thr Thr Ala Arg Leu Trp Gln Val Met Phe
545 550 555 560
Gly Asn Arg Met His Gly Ala Glu Leu Ala Arg Asp Asp Leu Val Ala
565 570 575
Leu Cys Arg Arg Gln Pro Thr Ala Thr Ala Ser Asn Gly Ala Ile Val
580 585 590
Asp Leu Thr Ala Ala Cys Thr Ala Leu Ser Arg Phe Asp Glu Arg Ala
595 600 605
Asp Leu Asp Ser Arg Gly Ala His Leu Phe Thr Glu Phe Ala Leu Ala
610 615 620
Gly Gly Ile Arg Phe Ala Asp Thr Phe Glu Val Thr Asp Pro Val Arg
625 630 635 640
Thr Pro Arg Arg Leu Asn Thr Thr Asp Pro Arg Val Arg Thr Ala Leu
645 650 655
Ala Asp Ala Val Gln Arg Leu Ala Gly Ile Pro Leu Asp Ala Lys Leu
660 665 670
Gly Asp Ile His Thr Asp Ser Arg Gly Glu Arg Arg Ile Pro Ile His
675 680 685
Gly Gly Arg Gly Glu Ala Gly Thr Phe Asn Val Ile Thr Asn Pro Leu
690 695 700
Val Pro Gly Val Gly Tyr Pro Gln Val Val His Gly Thr Ser Phe Val
705 710 715 720
Met Ala Val Glu Leu Gly Pro His Gly Pro Ser Gly Arg Gln Ile Leu
725 730 735
Thr Tyr Ala Gln Ser Thr Asn Pro Asn Ser Pro Trp Tyr Ala Asp Gln
740 745 750
Thr Val Leu Tyr Ser Arg Lys Gly Trp Asp Thr Ile Lys Tyr Thr Glu
755 760 765
Ala Gln Ile Ala Ala Asp Pro Asn Leu Arg Val Tyr Arg Val Ala Gln
770 775 780
Arg Gly Arg
785
Claims (9)
1. a kind of recombination echinocandin B deacylase mutant, it is characterised in that the deacylase mutant is by SEQ ID
The 287th, 527 progress single mutation of amino acid sequence shown in No.2 or double mutation obtain.
2. as described in claim 1 recombination echinocandin B deacylase mutant, it is characterised in that the mutant be it is following it
One: (1) the 287th glycine mutation of amino acid sequence shown in SEQ ID No.2 is glutamine;(2) shown in SEQ ID No.2
The 527th arginine of amino acid sequence sports valine;(3) the 287th glycine of amino acid sequence shown in SEQ ID No.2
Glutamine is sported, and the 527th arginine sports valine.
3. recombinating the recombination engineering bacteria of echinocandin B deacylase mutation construction described in a kind of claim 1.
4. engineering bacteria as claimed in claim 3, it is characterised in that the engineering bacteria constructs as follows: deacylase is dashed forward
Variant encoding gene is connect with strong constitutive promoter PermE*, and is connected to expression plasmid pSET152, and conversion enters E.coli
JM109 competence obtains deacylase mutant Escherichia coli cloning vector, extracts plasmid;By the recombinant plasmid transformed of acquisition
Into E.coli ET12567 competence, engagement transfer E. coli cloning vector is obtained;Engagement transfer imports lead-changing penicillium chain
Mould (Streptomyces lividans) TK24 screens positive recombinant, obtains the engineering of the mutant gene containing deacylase
Bacterium.
5. recombination echinocandin B deacylase mutant described in a kind of claim 1 is white in biocatalysis echinocandin B synthesis spine
Application in rhzomorph B parent nucleus.
6. application as claimed in claim 5, it is characterised in that the application method are as follows: recombination echinocandin B deacylation will be contained
The pure enzyme of deacylase mutant that the supernatant that the fermented culture of the engineering bacteria of base enzyme mutant gene obtains extracts is catalyst,
Using echinocandin B as substrate, reaction system is constituted by cosolvent of methanol, is carried out under the conditions of 35 degrees Celsius, 600 rpms
Reaction, reaction terminate, and reaction solution isolates and purifies, and obtain echinocandin B parent nucleus.
7. application as claimed in claim 6, it is characterised in that in the reaction system, echinocandin B final concentration of 0.1~
1.5 mMs every liter, catalyst amount is 1.00~5.02U/mL, and methanol volumetric concentration is 5%.
8. application as claimed in claim 6, it is characterised in that the catalyst is prepared as follows: will be contained deacylase and be dashed forward
1 mole of every liter of KH of the supernatant that the fermented culture of the engineering bacteria of variant gene obtains2PO4Adjust pH to 7.5, as crude enzyme liquid;
Crude enzyme liquid is successively filtered with microfiltration membranes, ultrafiltration membrane and nanofiltration membrane, takes the filtrate of nanofiltration membrane in pH 7.5,20 mmoles
Dialysed overnight in your every liter of kaliumphosphate buffer;In permeate after pH7.5,20 mMs of every liter of kaliumphosphate buffer balances
Bio-Rad HighS strong cat ion exchange column, then foreign protein is eluted with 0.1 mole of every liter of KCl aqueous solution, finally with 0.2 mole
Every liter of KCl aqueous solution elution, flow velocity are 1 milliliter per minute, destination protein are collected, in pH7.5,20 mMs of every liter of potassium phosphates
Dialysed overnight in buffer takes permeate, obtains the pure enzyme solution of deacylase, as catalyst.
9. the use as claimed in claim 7, it is characterised in that the fermentation liquid is prepared as follows: will be contained deacylase and be dashed forward
The engineering bacteria of variant gene is inoculated into the seed culture medium of the 25 micrograms per millilitre Pristinamycin containing final concentration, 28 degrees Celsius, 200
Rpm culture 3 days, as first order seed culture solution;Fresh seed culture is inoculated into the inoculum concentration of volumetric concentration 10%
In base, 28 degrees Celsius, 200 rpms are cultivated 2 days, as secondary seed culture solution;It is connect with the inoculum concentration of volumetric concentration 10%
Kind is into fresh fermentation medium, and 30 degrees Celsius, 200 rpms are cultivated 2.5 days, 4 degrees Celsius, 8000 rpms of centrifugations
10 minutes, obtain supernatant;The seed culture medium composition are as follows: peptone 10g/L, yeast extract 10g/L, NaCl 0.5g/
L、KH2PO4 1g/L、K2HPO4·3H2O 1.5g/L, uses H3PO4PH to 7.0 is adjusted with KOH, solvent is deionized water;The hair
Ferment culture medium composition: peptone 10g/L, yeast extract 10g/L, glucose 10g/L, NaCl 0.5g/L, KH2PO4 1g/L、
K2HPO4·3H2O 1.5g/L, uses H3PO4PH to 7.0 is adjusted with KOH, solvent is deionized water.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910155559.4A CN109897843B (en) | 2019-03-01 | 2019-03-01 | Recombinant echinocandin B deacylase mutant and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910155559.4A CN109897843B (en) | 2019-03-01 | 2019-03-01 | Recombinant echinocandin B deacylase mutant and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN109897843A true CN109897843A (en) | 2019-06-18 |
CN109897843B CN109897843B (en) | 2021-02-02 |
Family
ID=66946133
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910155559.4A Active CN109897843B (en) | 2019-03-01 | 2019-03-01 | Recombinant echinocandin B deacylase mutant and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109897843B (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113174398A (en) * | 2021-04-22 | 2021-07-27 | 浙江工业大学 | Expression cassette for recombinant expression of echinocandin B deacylase and application |
CN113215185A (en) * | 2021-04-22 | 2021-08-06 | 浙江工业大学 | Recombinant gene sequence for recombinant expression of echinocandin B deacylase |
CN115820694A (en) * | 2022-12-30 | 2023-03-21 | 天津科技大学 | Novel hyaluronidase encoding gene and high-yield engineering bacterium, construction method and application thereof |
WO2024017105A1 (en) * | 2022-07-18 | 2024-01-25 | 中国科学院青岛生物能源与过程研究所 | Transcription factor for improving yield of echinocandin compounds and use thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020137661A1 (en) * | 1997-12-08 | 2002-09-26 | Frances Arnold | Method for creating polynucleotide and polypeptide sequences |
CN108823179A (en) * | 2018-06-30 | 2018-11-16 | 浙江工业大学 | A kind of transaminase from actinomyces, mutant, recombinant bacterium and application |
-
2019
- 2019-03-01 CN CN201910155559.4A patent/CN109897843B/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020137661A1 (en) * | 1997-12-08 | 2002-09-26 | Frances Arnold | Method for creating polynucleotide and polypeptide sequences |
US20040180340A1 (en) * | 1997-12-08 | 2004-09-16 | Maxygen, Inc. | Method for creating polynucleotide and polypeptide sequences |
EP2270234A1 (en) * | 1997-12-08 | 2011-01-05 | California Institute of Technology | Method for creating polynucleotide and polypeptide sequences |
CN108823179A (en) * | 2018-06-30 | 2018-11-16 | 浙江工业大学 | A kind of transaminase from actinomyces, mutant, recombinant bacterium and application |
Non-Patent Citations (3)
Title |
---|
GENBANK: BAJ14711.1: "aculeacin A acylase [Actinoplanes utahensis]", 《GENBANK》 * |
LEI SHAO 等: "Efficient Bioconversion of Echinocandin B to Its Nucleus by Overexpression of Deacylase Genes in Different Host Strains", 《APPLIED AND ENVIRONMENTAL MICROBIOLOGY》 * |
赵国玲 等: "棘白霉素脱酰酶基因工程菌的构建及应用研究", 《中国生物工程杂志》 * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113174398A (en) * | 2021-04-22 | 2021-07-27 | 浙江工业大学 | Expression cassette for recombinant expression of echinocandin B deacylase and application |
CN113215185A (en) * | 2021-04-22 | 2021-08-06 | 浙江工业大学 | Recombinant gene sequence for recombinant expression of echinocandin B deacylase |
CN113215185B (en) * | 2021-04-22 | 2022-04-29 | 浙江工业大学 | Recombinant gene sequence for recombinant expression of echinocandin B deacylase |
CN113174398B (en) * | 2021-04-22 | 2022-04-29 | 浙江工业大学 | Expression cassette for recombinant expression of echinocandin B deacylase and application |
WO2024017105A1 (en) * | 2022-07-18 | 2024-01-25 | 中国科学院青岛生物能源与过程研究所 | Transcription factor for improving yield of echinocandin compounds and use thereof |
CN115820694A (en) * | 2022-12-30 | 2023-03-21 | 天津科技大学 | Novel hyaluronidase encoding gene and high-yield engineering bacterium, construction method and application thereof |
Also Published As
Publication number | Publication date |
---|---|
CN109897843B (en) | 2021-02-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109897843A (en) | A kind of recombination echinocandin B deacylase mutant and application | |
CN109486794B (en) | Chitinase mutant with improved enzyme activity | |
CN105802985B (en) | A method of fast implementing bacillus licheniformis gene knockout | |
CN115011616B (en) | Acetaldehyde dehydrogenase gene RKALDH and application thereof | |
CN110373404A (en) | A kind of enzyme mutant | |
CN109321552A (en) | A kind of novel Pullulanase and its gene, engineering bacteria and preparation method | |
CN104263710A (en) | Beta-galactosidase combined mutant with high transglycosylation activity as well as preparation method and application of beta-galactosidase combined mutant | |
CN106591271A (en) | Arginine deiminase mutant with improved enzyme activity and temperature stability and application of mutant | |
CN104450651B (en) | A kind of β glucosides enzyme mutant and its application | |
CN112301012B (en) | Cyclodextrin glucosyltransferase mutant and construction method thereof | |
CN112725319B (en) | Alginate lyase FaAly7 with polyG substrate specificity and application thereof | |
CN115960875A (en) | Alginate lyase mutant enzyme with improved thermal stability | |
CN108034667A (en) | A kind of red monascus alpha-amylase gene, its preparation method and application | |
CN108018216A (en) | Improve the method and application of sugar utilization and lemon acid yield in citric acid fermentation | |
CN109609524A (en) | Protein and the application of a kind of lactobacillus plantarum nitrite reductase gene and its coding | |
CN106119180A (en) | A kind of mycobacteria recombination engineering bacteria and application thereof | |
CN104152472A (en) | Diguanylate cyclase gene, vector, engineering bacteria and application | |
CN106047738A (en) | Recombinant pichia pastoris, construction method and application of recombinant pichia pastoris | |
CN104212787A (en) | Panax japonicas beta-amyrin synthase gene and application thereof | |
CN109957538A (en) | A kind of genetic engineering bacterium and its preparation method and application preparing sarcosine oxidase | |
CN113564151B (en) | Method for improving structural isomerism catalytic activity of CE enzyme and mutant thereof | |
CN109913515A (en) | A method of it improving bacillus glycerol metabolism and increases Polyurethane-epoxy resin yield | |
CN104894081A (en) | Alkaline thermal-stability SGNH family esterase EstD1 and gene thereof | |
CN108384800A (en) | Turn the cultivation, identification and application of CmWRKY15-1 gene Cut Flower Chrysanthemum Morifoliums | |
CN108102934A (en) | A kind of Aspergillus niger strain of high yield pectin lyase |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |